Patent US2468760A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4252653A Expired / Lapsed US ⏱️ 0.0 years remaining

Hemoperfusion device for specific modification or removal of components of whole blood

Assignee: Stolle Research and Development Corp
•
Filing: 1978-08-25
•
Granted: 1981-02-24
•
Expires: 1998-08-25
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A hemoperfusion device is disclosed for the specific modification or removal of components of whole blood. The device involves a 3-dimensional arrangement of fibers within a housing arranged to provide maximum exposed fiber surface and flow-channel diameter, while also reducing the tortuosity of the flow path. Desired effector molecules are bound to the fibers to allow them to contact the target components of the blood, whereby to remove the target components. Details of the fiber and effector molecules are disclosed and a specific device is described.

Inventors

  • 👤 Lee R. Beck
  • 👤 Thomas A. Davis

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 13:18
CPC Classifications
A; A61; A61M; A61M1/00; A61M1/36; A61M1/3679; B; B01; B01D; B01D15/00; B01D15/08

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 212 words
A hemoperfusion device comprising an elongated housing of impermeable material, closed at its ends by means of impermeable end plates, said housing on its interior having a plurality of axial ribs extending substantially throughout the length thereof, an inlet port in one of said end plates, an outlet port in the other of said end plates, said ribs continuing radially in said other of said end plates, an impermeable spindle axially disposed in said housing and having axially disposes grooves in its periphery, a conical port secured to one end of said spindle and in communication with said inlet port and with said grooves, said spindle at its other end terminating in a conical tip axially disposed with respect to said outlet port with an annular space therebetween, and a spool of fiber helically wound on said spindle to substantially fill the interior of said housing to said ribs, whereby blood entering said inlet port flows along said spindle grooves, passes through said fiber spool, flows along the inside of said housing between said ribs, and thence between said conical tip and said outlet port, said fiber having attached thereon specific effector molecules having activity to remove biological fluid components of endogenous or exogenous origin from blood being perfused through said device.
Claim 2
Dependent Claim 212 words
A hemoperfusion device comprising an elongated housing of impermeable material, closed at its ends by means of impermeable end plates, said housing on its interior having a plurality of axial ribs extending substantially throughout the length thereof, an inlet port in one of said end plates, an outlet port in the other of said end plates, said ribs continuing radially in said other of said end plates, an impermeable spindle axially disposed in said housing and having axially disposes grooves in its periphery, a conical port secured to one end of said spindle and in communication with said inlet port and with said grooves, said spindle at its other end terminating in a conical tip axially disposed with respect to said outlet port with an annular space therebetween, and a spool of fiber helically wound on said spindle to substantially fill the interior of said housing to said ribs, whereby blood entering said inlet port flows along said spindle grooves, passes through said fiber spool, flows along the inside of said housing between said ribs, and thence between said conical tip and said outlet port, said fiber having attached thereon specific effector molecules having activity to remove biological fluid components of endogenous or exogenous origin from blood being perfused through said device.
Claim 3
Dependent Claim 52 words
The hemoperfusion device of claim 1 wherein said fiber is a monofilament having a diameter between about 0.05 mm and about 2.0 mm, on which effector molecules can be immobilized in such manner that they are free to react chemically with factors in the blood, thereby removing such factors from the blood.
Claim 4
Dependent Claim 13 words
The hemoperfusion device of claim 2 wherein said fiber is of hydroxyethyl cellulose.

References Cited (Backward Citations)

US2284787A Cited
US3390779A Cited
US4061141A Cited
US4048064A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1984-02-24 1984-08-25 1985-02-24 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1988-02-24 1988-08-25 1989-02-24 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1992-02-24 1992-08-25 1993-02-24 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag